Cargando…

Nuclear medicine imaging in the evaluation of endocrine hypertension

Endocrine hypertension forms a small (< 5%) but curable subset of patients with hypertension. Common endocrine causes of hypertension include pheochromocytoma, Cushing's syndrome, primary hyperaldosteronism, and thyroid disorders. Nuclear medicine imaging plays an important role in evaluatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Punit, Kumar, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475893/
https://www.ncbi.nlm.nih.gov/pubmed/23087853
http://dx.doi.org/10.4103/2230-8210.100655
_version_ 1782247000533630976
author Sharma, Punit
Kumar, Rakesh
author_facet Sharma, Punit
Kumar, Rakesh
author_sort Sharma, Punit
collection PubMed
description Endocrine hypertension forms a small (< 5%) but curable subset of patients with hypertension. Common endocrine causes of hypertension include pheochromocytoma, Cushing's syndrome, primary hyperaldosteronism, and thyroid disorders. Nuclear medicine imaging plays an important role in evaluation of patients with endocrine hypertension. It has established role in patients of pheochromocytoma/paraganglioma, Cushing's syndrome, aldosteronism, and thyroid disorders. We present a brief overview of role of nuclear medicine imaging in endocrine hypertension. Development of newer radiotracers might further broaden the role of nuclear medicine in these patients.
format Online
Article
Text
id pubmed-3475893
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34758932012-10-19 Nuclear medicine imaging in the evaluation of endocrine hypertension Sharma, Punit Kumar, Rakesh Indian J Endocrinol Metab Review Article Endocrine hypertension forms a small (< 5%) but curable subset of patients with hypertension. Common endocrine causes of hypertension include pheochromocytoma, Cushing's syndrome, primary hyperaldosteronism, and thyroid disorders. Nuclear medicine imaging plays an important role in evaluation of patients with endocrine hypertension. It has established role in patients of pheochromocytoma/paraganglioma, Cushing's syndrome, aldosteronism, and thyroid disorders. We present a brief overview of role of nuclear medicine imaging in endocrine hypertension. Development of newer radiotracers might further broaden the role of nuclear medicine in these patients. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3475893/ /pubmed/23087853 http://dx.doi.org/10.4103/2230-8210.100655 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sharma, Punit
Kumar, Rakesh
Nuclear medicine imaging in the evaluation of endocrine hypertension
title Nuclear medicine imaging in the evaluation of endocrine hypertension
title_full Nuclear medicine imaging in the evaluation of endocrine hypertension
title_fullStr Nuclear medicine imaging in the evaluation of endocrine hypertension
title_full_unstemmed Nuclear medicine imaging in the evaluation of endocrine hypertension
title_short Nuclear medicine imaging in the evaluation of endocrine hypertension
title_sort nuclear medicine imaging in the evaluation of endocrine hypertension
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475893/
https://www.ncbi.nlm.nih.gov/pubmed/23087853
http://dx.doi.org/10.4103/2230-8210.100655
work_keys_str_mv AT sharmapunit nuclearmedicineimagingintheevaluationofendocrinehypertension
AT kumarrakesh nuclearmedicineimagingintheevaluationofendocrinehypertension